23,308 reports of this reaction
8.7% of all Spiriva reports
#1 most reported adverse reaction
INCORRECT ROUTE OF DRUG ADMINISTRATION is the #1 most commonly reported adverse reaction for Spiriva, manufactured by Boehringer Ingelheim Pharmaceuticals, Inc.. There are 23,308 FDA adverse event reports linking Spiriva to INCORRECT ROUTE OF DRUG ADMINISTRATION. This represents approximately 8.7% of all 266,551 adverse event reports for this drug.
Patients taking Spiriva who experience incorrect route of drug administration should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INCORRECT ROUTE OF DRUG ADMINISTRATION is moderately reported among Spiriva users, representing a notable but not dominant share of adverse events.
In addition to incorrect route of drug administration, the following adverse reactions have been reported for Spiriva:
The following drugs have also been linked to incorrect route of drug administration in FDA adverse event reports:
INCORRECT ROUTE OF DRUG ADMINISTRATION has been reported as an adverse event in 23,308 FDA reports for Spiriva. This does not prove causation, but indicates an association observed in post-market surveillance data.
INCORRECT ROUTE OF DRUG ADMINISTRATION accounts for approximately 8.7% of all adverse event reports for Spiriva, making it one of the most commonly reported side effect.
If you experience incorrect route of drug administration while taking Spiriva, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.